PGD uses In-vitro Fertilization (IVF) to acquire an early-stage embryo. This embryo is then assessed by our medical professionals to determine its sex or screen for certain genetic conditions before it is implanted into the mother’s uterus. Using PGD to determine the baby’s sex before implantation has a 99 percent accuracy rate and is a popular service for our parents-to-be who want to select their baby’s gender.
These parents wish to make this decision for a number of reasons. For example, some families who already have a girl wish to now have a baby boy, or vice versa. It is also a priceless service for parents-to-be with certain medical conditions as they may be at risk of transmitting these conditions to their baby. With PGD, we can protect your future baby by testing for aneuploidy, single-gene disorders, and translocations with PGD.
While PGD does have an exceptionally high accuracy rate for determining the sex of an embryo, it is known to have the risk of false negative or false positive results for genetic testing. This inaccuracy is the result of chromosomal inconsistencies that are often seen in the embryo’s cells. PGD may also reduce the overall success rate of an IVF procedure, which should be a consideration especially for cases where there is a limited number of embryos, so it is not recommended for every family. Despite these risks, PGD can still be an effective solution for parents-to-be who are concerned about their baby’s future health. If your family is considering PGD for sex selection or genetic screening, we encourage you to reach out to your program coordinator. Your medical professional will want to review your egg retrieval results and the number of available developing embryos and discuss your wants and needs, so you can make an informed decision before approving the PGD service.